Market Overview:
The global nerve stimulator market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of chronic diseases, technological advancements in nerve stimulators, and rising demand for minimally invasive surgeries. Based on type, the global nerve stimulator market is segmented into deep brain stimulator (DBS), vagus nerve stimulator (VNS), and spinal cord stimulator (SCS). The DBS segment is expected to account for the largest share of the global nerve stimulator market in 2018. This can be attributed to its growing use in treating various neurological disorders such as Parkinson’s disease, epilepsy, and dystonia. Based on application, the global nerve stimulator market is segmented into chronic pain management, depression management, dystonia treatment, epilepsy treatment, and Parkinson’s disease treatment. The chronic pain management segment accounted for the largest share of the global nerve stimulator market in 2017 owing to its high prevalence across different regions worldwide.
Product Definition:
A nerve stimulator is a device that sends electrical impulses to nerves to help control pain or improve function.
Deep Brain Stimulator:
A deep brain stimulator is a medical device used for the treatment of various neurological disorders such as Parkinson's disease, dystonia, essential tremor and epilepsy. The DBS (Deep Brain Stimulation) market is expected to witness lucrative growth over the forecast period owing to factors such as increasing prevalence of neurological diseases coupled with rising awareness about these devices among patients & physicians.
Vagus Nerve Stimulator:
The vagus nerve stimulator is a device that sends regular and mild electrical impulses to the brain to help with various mental disorders such as anxiety, depression, bipolar disorder, obsessive-compulsive disorder (OCD), Alzheimer's disease and Parkinson's disease. The treatment helps in improving symptoms of these diseases by changing the way the nervous system reacts to stress.
Application Insights:
The chronic pain segment dominated the global market in 2017. The growing prevalence of chronic diseases, such as cancer and diabetes, is anticipated to boost the demand for neurostimulators. In addition, an increase in the incidence of disorders related to back pain is projected to propel product demand over the forecast period. For instance, according to a study published by NCBI in 2018, around 60% of adults suffer from some form of lower back pain every year and this number increases with age group 55+.
The depression segment held a significant share on account of increasing prevalence rates across various regions including Asia Pacific and North America. According to WHO's 2019 World Mental Health Survey Report; more than half a billion people aged 15 or above have experienced one or more major mental illnesses during their lifetime globally which constitute 20%of all disease burden in 2015.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of a large number of patients suffering from neurodegenerative and psychiatric disorders, increasing prevalence of chronic pain, and rising adoption of innovative technologies. Moreover, an increase in government funding for R&D activities pertaining to neurological diseases is also expected to drive growth during the forecast period. For instance, according to statistics published by Parkinson’s Foundation International in 2018, around 60 million people worldwide are living with Parkinson's disease (PD) which constitutes about 1% of all adults over age 50. In addition it was reported that approximately 609 thousand new cases were diagnosed in U.S., which constituted about 115 cases per 100 thousand population in 2016.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace and this is expected to drive the demand for nerve stimulators in the coming years.
- Rising prevalence of neurological disorders: The prevalence of various neurological disorders such as Parkinson’s disease, cerebral palsy, and multiple sclerosis is rising rapidly across the world. This is likely to boost the demand for nerve stimulators in the near future.
- Growing awareness about benefits of nerve stimulation therapy: There is growing awareness among people about the benefits of using nerve stimulator devices for treating various neurological conditions. This is likely to propel market growth in the coming years.
- Technological advancements: The technological advancements in nerve stimulator devices are helping to improve their efficacy and safety profile, which is resulting in an increase in their adoption rates worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Nerve Stimulator Market Research Report
By Type
Deep Brain Stimulator, Vagus Nerve Stimulator, Spinal Cord Stimulator
By Application
Chronic Pain, Depression, Dystonia, Epilepsy, Parkinson’s Disease
By Companies
Boston Scientific, Cochlear, Medtronic, St Jude Medical, Cyberonics, Aleva Neurotherapeutics, NeuroPace, ...
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Nerve Stimulator Market Report Segments:
The global Nerve Stimulator market is segmented on the basis of:
Types
Deep Brain Stimulator, Vagus Nerve Stimulator, Spinal Cord Stimulator
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Chronic Pain, Depression, Dystonia, Epilepsy, Parkinson’s Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Boston Scientific
- Cochlear
- Medtronic
- St Jude Medical
- Cyberonics
- Aleva Neurotherapeutics
- NeuroPace
- ...
Highlights of The Nerve Stimulator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Deep Brain Stimulator
- Vagus Nerve Stimulator
- Spinal Cord Stimulator
- By Application:
- Chronic Pain
- Depression
- Dystonia
- Epilepsy
- Parkinson’s Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nerve Stimulator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A nerve stimulator is a medical device that stimulates nerves to improve function.
Some of the major companies in the nerve stimulator market are Boston Scientific, Cochlear, Medtronic, St Jude Medical, Cyberonics, Aleva Neurotherapeutics, NeuroPace.
The nerve stimulator market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nerve Stimulator Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Nerve Stimulator Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Nerve Stimulator Market - Supply Chain
4.5. Global Nerve Stimulator Market Forecast
4.5.1. Nerve Stimulator Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Nerve Stimulator Market Size (000 Units) and Y-o-Y Growth
4.5.3. Nerve Stimulator Market Absolute $ Opportunity
5. Global Nerve Stimulator Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Nerve Stimulator Market Size and Volume Forecast by Type
5.3.1. Deep Brain Stimulator
5.3.2. Vagus Nerve Stimulator
5.3.3. Spinal Cord Stimulator
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Nerve Stimulator Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Nerve Stimulator Market Size and Volume Forecast by Application
6.3.1. Chronic Pain
6.3.2. Depression
6.3.3. Dystonia
6.3.4. Epilepsy
6.3.5. Parkinsons Disease
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Nerve Stimulator Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Nerve Stimulator Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Nerve Stimulator Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Nerve Stimulator Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Nerve Stimulator Demand Share Forecast, 2019-2029
9. North America Nerve Stimulator Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Nerve Stimulator Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Nerve Stimulator Market Size and Volume Forecast by Application
9.4.1. Chronic Pain
9.4.2. Depression
9.4.3. Dystonia
9.4.4. Epilepsy
9.4.5. Parkinsons Disease
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Nerve Stimulator Market Size and Volume Forecast by Type
9.7.1. Deep Brain Stimulator
9.7.2. Vagus Nerve Stimulator
9.7.3. Spinal Cord Stimulator
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Nerve Stimulator Demand Share Forecast, 2019-2029
10. Latin America Nerve Stimulator Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Nerve Stimulator Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Nerve Stimulator Market Size and Volume Forecast by Application
10.4.1. Chronic Pain
10.4.2. Depression
10.4.3. Dystonia
10.4.4. Epilepsy
10.4.5. Parkinsons Disease
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Nerve Stimulator Market Size and Volume Forecast by Type
10.7.1. Deep Brain Stimulator
10.7.2. Vagus Nerve Stimulator
10.7.3. Spinal Cord Stimulator
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Nerve Stimulator Demand Share Forecast, 2019-2029
11. Europe Nerve Stimulator Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Nerve Stimulator Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Nerve Stimulator Market Size and Volume Forecast by Application
11.4.1. Chronic Pain
11.4.2. Depression
11.4.3. Dystonia
11.4.4. Epilepsy
11.4.5. Parkinsons Disease
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Nerve Stimulator Market Size and Volume Forecast by Type
11.7.1. Deep Brain Stimulator
11.7.2. Vagus Nerve Stimulator
11.7.3. Spinal Cord Stimulator
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Nerve Stimulator Demand Share, 2019-2029
12. Asia Pacific Nerve Stimulator Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Nerve Stimulator Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Nerve Stimulator Market Size and Volume Forecast by Application
12.4.1. Chronic Pain
12.4.2. Depression
12.4.3. Dystonia
12.4.4. Epilepsy
12.4.5. Parkinsons Disease
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Nerve Stimulator Market Size and Volume Forecast by Type
12.7.1. Deep Brain Stimulator
12.7.2. Vagus Nerve Stimulator
12.7.3. Spinal Cord Stimulator
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Nerve Stimulator Demand Share, 2019-2029
13. Middle East & Africa Nerve Stimulator Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Nerve Stimulator Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Nerve Stimulator Market Size and Volume Forecast by Application
13.4.1. Chronic Pain
13.4.2. Depression
13.4.3. Dystonia
13.4.4. Epilepsy
13.4.5. Parkinsons Disease
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Nerve Stimulator Market Size and Volume Forecast by Type
13.7.1. Deep Brain Stimulator
13.7.2. Vagus Nerve Stimulator
13.7.3. Spinal Cord Stimulator
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Nerve Stimulator Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Nerve Stimulator Market: Market Share Analysis
14.2. Nerve Stimulator Distributors and Customers
14.3. Nerve Stimulator Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Boston Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Cochlear
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. St Jude Medical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cyberonics
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aleva Neurotherapeutics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. NeuroPace
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. ...
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
